Azacitidine and Novalgin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azacitidine (azacitidine) and Novalgin (metamizole). Common drug interactions include neutropenia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Azacitidine and Novalgin. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

What is Novalgin?

Novalgin has active ingredients of metamizole. It is often used in pain. eHealthMe is studying from 10,177 Novalgin users. Check the latest studies of Novalgin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

56 people who take Azacitidine and Novalgin together, and have interactions are studied.

Azacitidine and Novalgin drug interactions.

What are the common drug interactions of Azacitidine and Novalgin, by gender? *:

female:

Neutropenia (an abnormally low number of neutrophils)
Leukopenia (less number of white blood cells in blood)
Diarrhoea
Anaemia (lack of blood)
Thrombocytopenia (decrease of platelets in blood)
Nausea (feeling of having an urge to vomit)
Fatigue (feeling of tiredness)
Infection
Contusion (a type of hematoma of tissue in which capillaries)
Hypertension (high blood pressure)

male:

Febrile neutropenia (fever with reduced white blood cells)
Thrombocytopenia (decrease of platelets in blood)
Blood creatinine increased
Cholecystitis (infection of gallbladder)
Decreased appetite
Hepatic infection fungal
Nausea (feeling of having an urge to vomit)
Oropharyngeal pain
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Azacitidine and Novalgin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pancreas infection

40-49:

Alanine aminotransferase increased
Anaemia (lack of blood)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Infection
Injection site reaction
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Platelet count decreased
White blood cell count decreased

50-59:

Interstitial lung disease
C-reactive protein increased
Infection
Lung disorder (lung disease)

60+:

Neutropenia (an abnormally low number of neutrophils)
Anaemia (lack of blood)
C-reactive protein increased
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Sepsis (a severe blood infection that can lead to organ failure and death)
Contusion (a type of hematoma of tissue in which capillaries)
Depression
Hypertension (high blood pressure)
Infection
Influenza

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 35 people, 62.50%
Nausea (feeling of having an urge to vomit): 19 people, 33.93%
High Blood Pressure: 19 people, 33.93%
Constipation: 17 people, 30.36%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 16 people, 28.57%
Hyperlipidaemia (presence of excess lipids in the blood): 12 people, 21.43%
Sleep Disorder: 10 people, 17.86%
Back Pain: 8 people, 14.29%
Insomnia (sleeplessness): 7 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Azacitidine and Novalgin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously